The Form 4 filing, an SEC report of insider stock transactions, was filed on November 12, 2026. Both sales took place on November 10, 2026, two days before the filing date.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-10 |
| Date of Latest Transaction | 2026-11-10 |
| Buy/Sell | sell |
| Transaction Count | 2 |
| Shares Transacted | 41,666 |
| Price | $75.16 |
| Total Transaction Value | $3,131,547.49 |
| Insider | |
| Ticker Symbol | GMED |
| Company | GLOBUS MEDICAL INC |
| Insider Name | TOBIN JAMES R |
| Insider Title | Director |
| Sector - Industry | Healthcare - Medical Devices |
| Holdings | |
| Total Shares Owned After Transaction | 0 |
| Position Size Change | 100.00% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales under transaction code S, which identifies a sale. James R. Tobin made two reported sales of Globus Medical (GMED) shares.
What was the average price of the transaction?
The average sale price was $75.16 per share. That average covers the 41,666 shares sold across the two transactions.
How did this transaction affect the insider's holdings?
He sold 41,666 shares and reported zero shares owned afterward. The sales covered 100.00% of the shares in the reported balance before the trades. Any holdings outside that reported balance remain unknown.
What's the total transaction value?
The two sales had a combined total value of $3,131,547.49, rounded to the nearest cent.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement for these sales. Filing footnote text was unavailable, so further details about any arrangements remain unknown.
For research purposes only; not investment advice.